Product Details for ANDA 083009
ORASONE (PREDNISONE)
1MG
Marketing Status: Discontinued
5MG
Marketing Status: Discontinued
10MG
Marketing Status: Discontinued
20MG
Marketing Status: Discontinued
1MG
Marketing Status: Discontinued
Active Ingredient: PREDNISONE
Proprietary Name: ORASONE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083009
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SOLVAY PHARMACEUTICALS
Marketing Status: Discontinued
Patent and Exclusivity Information
ORASONE (PREDNISONE)
Proprietary Name: ORASONE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083009
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SOLVAY PHARMACEUTICALS
Marketing Status: Discontinued
Patent and Exclusivity Information
5MG
Marketing Status: Discontinued
Active Ingredient: PREDNISONE
Proprietary Name: ORASONE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083009
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SOLVAY PHARMACEUTICALS
Marketing Status: Discontinued
Patent and Exclusivity Information
ORASONE (PREDNISONE)
Proprietary Name: ORASONE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083009
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SOLVAY PHARMACEUTICALS
Marketing Status: Discontinued
Patent and Exclusivity Information
10MG
Marketing Status: Discontinued
Active Ingredient: PREDNISONE
Proprietary Name: ORASONE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083009
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SOLVAY PHARMACEUTICALS
Marketing Status: Discontinued
Patent and Exclusivity Information
ORASONE (PREDNISONE)
Proprietary Name: ORASONE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083009
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SOLVAY PHARMACEUTICALS
Marketing Status: Discontinued
Patent and Exclusivity Information
20MG
Marketing Status: Discontinued
Active Ingredient: PREDNISONE
Proprietary Name: ORASONE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083009
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SOLVAY PHARMACEUTICALS
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: ORASONE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083009
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SOLVAY PHARMACEUTICALS
Marketing Status: Discontinued
Patent and Exclusivity Information